5th International Symposium on the Environmental Dimension of Antibiotic Resistance

9–14 June 2019 • Hong Kong

5th International Symposium on the Environmental Dimension of Antibiotic Resistance

9–14 June 2019 • Hong Kong

Congress Details

Abstract submission

Print-File

Abstract Submission

Potential authors are invited to submit an abstract (maximum length 2,000 characters) in English, related to one of the major topics outline below. The International Scientific Committee will review the abstracts according to scientific content and suitability for the conference. The majority of abstracts are expected to be accepted for oral or poster presentations.

Deadline of Abstract Submission: 1 February, 2019.

BASIC SCIENCE UNDERPINNING AMR

1. Natural resistome, selection and evolution
- Natural reservoirs of ARGs and MGEs in water, soil, and any native biota
- Selection, co-selection, sub-inhibitory concentration
- Evolutionary change, adaptations
- Cultivation/phenotype vs sequencing/genotype
- Bioinformatic or experimental studies aimed at new ARG discovery 

2. ARG genetic linkages, gene/plasmid mobility, HGT
- Plasmid ecology
- Gene mobility
- Metagenomic assembly, long reads
- Bioinformatics tools, databases, ARG nomenclature
- In silico analysis of ARGs in whole genome collection
- Single cell analyses

3. Environmental antibiotic chemistry, bioavailability, biodegradation, and metabolism
- Environmental conditions for selection
- Fate, transport and biotransformation of antibiotics
- Antibiotic residues in different environments and resource settings

ADVANCES IN CHARACTERIZING ENVIRONMENTAL SOURCES, CONSEQUENCES, STEWARDSHIP AND/OR MITIGATION

4. AMR/ARG sources, mitigation: terrestrial and agriculture
- Animal agriculture at different scales and resource settings
- Wildlife, pets
- Manure/sludge management, treatment, AMR ecology in manures/sludge
- Treated wastewater irrigation
- Horticultural uses
- ARG cycling via animal workers 

5. AMR/ARG sources, mitigation: water environments
- Municipal wastewater treatment
- Drinking water
- Recycled water
- Streams, lakes, sediments, estuaries, ocean

6. AMR/ARG sources, mitigation: aquaculture, production, hospitals, other
- Caged fish, shellfish
- Pharmaceutical wastewater and treatment technology
- Medical uses and disposal in different resource settings
- Hospital wastewater and treatment

LARGER SCALE STUDIES, HUMAN IMPACT, RISK, CONSUMER ENGAGEMENT

7. Assessment, mitigation, stewardship; human impact
- One-Health studies linking risk of AMR infection in humans to animal and environmental reservoirs
- Updates on multidrug resistant strains (superbugs) of environmental relevance, lessons learned
- Farm to fork AMR/food safety studies, outcome to humans

8. Risk scenarios, assessment, modelling
- Quantitative risk assessment, directions of AMR bacteria/gene flow
- Examples of risk evaluation and/or stewardship approaches in low and middle-income countries
- Modelling to evaluate fate, human exposure and transmission pathways
- Clinical evidences of potential exposure to environmental AMR

9. Consumer trends, public communication, engagement
- Studies of AMR and the consumer
- Communicating AMR, stewardship to the producer and consumer

PROGRAM/POLICY DIRECTIONS

10. National program, sector outcomes, policy, initiatives
- Larger scale studies by animal, fish, water treatment industry
- Outcomes from national programs to minimize AMR risk
- Regulatory, incentive perspectives, outcomes

Contact:
Conventus Congressmanagement & Marketing GmbH
Stefan Regge
Carl-Pulfrich-Straße 1
07745 Jena, Germany
Phone +49 3641 31 16-161
Fax +49 3641 31 16-243
abstract@conventus.de
www.conventus.de